R-MA regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx. ==Regimen== {{chemo|x|xx}} {{chemo|x|xx}}..." |
|||
Line 9: | Line 9: | ||
==Regimen== | ==Regimen== | ||
{{chemo| | {{chemo|R|Rituximab}} | ||
{{chemo| | {{chemo|M|Methotrexate}} | ||
{{chemo| | {{chemo|A|Cytarabine (Ara-C)}} | ||
==Indications== | ==Indications== |
Revision as of 17:46, 31 March 2015
WikiDoc Resources for R-MA regimen |
Articles |
---|
Most recent articles on R-MA regimen Most cited articles on R-MA regimen |
Media |
Powerpoint slides on R-MA regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on R-MA regimen at Clinical Trials.gov Clinical Trials on R-MA regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on R-MA regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on R-MA regimen Discussion groups on R-MA regimen Patient Handouts on R-MA regimen Directions to Hospitals Treating R-MA regimen Risk calculators and risk factors for R-MA regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for R-MA regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
R-MA regimen refers to a regimen consisting of xxx used to treat xxx.
Regimen
RRituximab
MMethotrexate
ACytarabine (Ara-C)